Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIMAVANSERIN for Depression: Side Effects & Safety Data

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

There are 18 adverse event reports in the FDA FAERS database where PIMAVANSERIN was used for Depression.

Most Reported Side Effects for PIMAVANSERIN

Side Effect Reports % Deaths Hosp.
Hallucination 10,839 23.4% 1,365 1,797
Death 9,352 20.2% 9,343 1,151
Drug ineffective 5,545 12.0% 440 544
Product dose omission issue 3,808 8.2% 655 928
Confusional state 3,779 8.2% 477 692
Fall 3,366 7.3% 712 1,589
Delusion 2,421 5.2% 349 488
Hallucination, visual 1,954 4.2% 256 342
Gait disturbance 1,923 4.2% 208 311
Parkinson's disease 1,918 4.1% 1,286 445
Condition aggravated 1,914 4.1% 244 299
Somnolence 1,510 3.3% 205 259
Peripheral swelling 1,479 3.2% 204 245
Urinary tract infection 1,452 3.1% 355 836
Adverse drug reaction 1,424 3.1% 102 197

Other Indications for PIMAVANSERIN

Parkinson's disease psychosis (25,572) Parkinson's disease (20,674) Hallucination (16,825) Delusion (14,563) Product used for unknown indication (1,132) Psychotic disorder (715) Dementia (526) Dementia with lewy bodies (467) Psychotic disorder due to a general medical condition (357) Hallucination, visual (269)

Other Drugs Used for Depression

SERTRALINE (14,497) VENLAFAXINE (11,868) DULOXETINE (11,681) ESKETAMINE (10,058) ESCITALOPRAM OXALATE (7,373) FLUOXETINE (7,035) BUPROPION (6,165) MIRTAZAPINE (6,021) CITALOPRAM HYDROBROMIDE (5,450) PAROXETINE (5,386)

Related Pages

PIMAVANSERIN Full Profile All Depression Drugs PIMAVANSERIN Demographics PIMAVANSERIN Timeline